Table 2 The prevalence of BRAF fusions in each acinar carcinoma histologic subtype
From: A FISH assay efficiently screens for BRAF gene rearrangements in pancreatic acinar-type neoplasms
Histologic subtype | Number of cases | Number of BRAF fusions (%) | Number of SND1–BRAF fusions |
|---|---|---|---|
Pure acinar cell carcinoma | 26 | 5 (19%) | 1 |
Mixed acinar cell/neuroendocrine carcinoma | 13 | 2 (20%) | 0 |
Mixed acinar cell/ductal carcinoma | 5 | 4 (80%) | 4 |
Mixed acinar cell/neuroendocrine/ductal carcinoma | 5 | 1 (20%) | 1 |
